GH insider transaction filings
Guardant Health, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-21. Screen GH transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 33 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing by 1 insider — 600 shares, $78,456 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 34 legs across 14 filings by 10 insiders — 444,071 shares, $70,161,567 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 110.
- Largest priced transaction: sale of 70,513 shares @ $151.47 ($10,680,315) by Talasaz AmirAli, filed 2026-06-30.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Talasaz AmirAli — Co-Chief Executive Officer, Director | 4 | — | 9 legs · 297,500 sh · $45,656,038 | 14 |
| Freeman Chris — Chief Commercial Officer | 2 | — | 4 legs · 63,605 sh · $10,786,111 | 13 |
| Monroe Terilyn J. — Chief People Officer | 2 | — | 5 legs · 46,300 sh · $7,645,218 | 9 |
| CLARK IAN T — Director | 1 | — | 2 legs · 14,180 sh · $2,253,451 | 4 |
| Chudova Darya — Chief Technology Officer | 2 | — | 1 leg · 7,738 sh · $1,377,364 | 9 |
| Krognes Steve E. — Director | 2 | — | 4 legs · 6,674 sh · $1,172,886 | 2 |
| Kalia Kumud — Chief Information Officer | 3 | 1 leg · 600 sh · $78,456 | 3 legs · 5,200 sh · $789,357 | 9 |
| Hidalgo Medina Manuel — Director | 4 | — | 2 legs · 1,700 sh · $279,202 | 8 |
| Azar Alex M II — Director | 2 | — | 1 leg · 826 sh · $144,550 | 2 |
| Tariq Musa — Director | 3 | — | 3 legs · 348 sh · $57,390 | 6 |
+4 more insiders in the window, not shown — every filing appears in the table below.
Recent Form 4 filings — Guardant Health, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | Hidalgo Medina Manuel — Director | Option exercise (M): 232 @ $0 · Option exercise (M): 232 (derivative) @ $0 | EDGAR |
| 2026-09-17 | 4 | Tariq Musa — Director | Option exercise (M): 249 @ $0 · Sale (S): 116 @ $175 · Option exercise (M): 249 (derivative) @ $0 | EDGAR |
| 2026-09-17 | 4 | Azar Alex M II — Director | Sale (S): 826 @ $175 | EDGAR |
| 2026-09-17 | 4 | Krognes Steve E. — Director | Sale (S): 1,103 @ $174.46 · Sale (S): 3,300 @ $175.42 · Sale (S): 1,300 @ $176.34 · Sale (S): 971 @ $177.48 | EDGAR |
| 2026-09-17 | 4 | Chudova Darya — Chief Technology Officer | Sale (S): 7,738 @ $178 | EDGAR |
| 2026-09-14 | 4 | Kalia Kumud — Chief Information Officer | Sale (S): 4,000 @ $158.05 | EDGAR |
| 2026-09-14 | 4 | Azar Alex M II — Director | Option exercise (M): 1,651 @ $0 · Option exercise (M): 1,651 (derivative) @ $0 | EDGAR |
| 2026-08-27 | 4 | Eltoukhy Helmy — Co-Chief Executive Officer, Director | Other (J): 25,000 @ $0 · Other (J): 25,000 @ $0 · Gift (G): 30,000 @ $0 | EDGAR |
| 2026-08-24 | 4 | MIGNONE ROBERTO — Director | Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2026-08-24 | 4 | Talasaz AmirAli — Co-Chief Executive Officer, Director | Sale (S): 9,023 @ $168.20 · Sale (S): 20,888 @ $169.16 · Sale (S): 7,589 @ $170.29 | EDGAR |
| 2026-08-18 | 4 | Tariq Musa — Director | Option exercise (M): 250 @ $0 · Sale (S): 116 @ $156.45 · Option exercise (M): 250 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Hidalgo Medina Manuel — Director | Option exercise (M): 232 @ $0 · Option exercise (M): 232 (derivative) @ $0 | EDGAR |
| 2026-08-13 | 4 | Monroe Terilyn J. — Chief People Officer | Option exercise (M): 32,288 @ $20.14 · Option exercise (M): 14,012 @ $28.61 · Sale (S): 3,704 @ $163.41 · Sale (S): 9,934 @ $164.27 · Sale (S): 19,014 @ $165.16 · Sale (S): 13,248 @ $166.11 · +3 more | EDGAR |
| 2026-08-12 | 4 | Eltoukhy Helmy — Co-Chief Executive Officer, Director | Gift (G): 35,000 @ $0 · Gift (G): 35,000 @ $0 | EDGAR |
| 2026-08-12 | 4 | Saia John G. — Chief Legal Officer | Gift (G): 800 @ $0 | EDGAR |
| 2026-08-12 | 4 | Talasaz AmirAli — Co-Chief Executive Officer, Director | Gift (G): 75,000 @ $0 · Gift (G): 75,000 @ $0 | EDGAR |
| 2026-08-11 | 4 | Freeman Chris — Chief Commercial Officer | Option exercise (M): 35,412 @ $110.49 · Option exercise (M): 28,193 @ $28.37 · Sale (S): 3,463 @ $167.38 · Sale (S): 7,365 @ $168.79 · Sale (S): 35,364 @ $169.63 · Sale (S): 17,413 @ $170.24 · +2 more | EDGAR |
| 2026-08-06 | 4 | Hidalgo Medina Manuel — Director | Option exercise (M): 950 @ $32.55 · Sale (S): 950 @ $163.94 · Sale (S): 750 @ $164.61 · Option exercise (M): 950 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | CLARK IAN T — Director | Option exercise (M): 2,255 @ $91.11 · Option exercise (M): 6,833 @ $50.57 · Sale (S): 9,088 @ $158.98 · Sale (S): 5,092 @ $158.80 · Option exercise (M): 2,255 (derivative) @ $0 · Option exercise (M): 6,833 (derivative) @ $0 | EDGAR |
| 2026-07-22 | 4 | MIGNONE ROBERTO — Director | Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | Hidalgo Medina Manuel — Director | Option exercise (M): 232 @ $0 · Option exercise (M): 232 (derivative) @ $0 | EDGAR |
| 2026-07-16 | 4 | Tariq Musa — Director | Option exercise (M): 250 @ $0 · Sale (S): 116 @ $163.29 · Option exercise (M): 250 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Chudova Darya — Chief Technology Officer | Option exercise (M): 1,339 @ $0 · Option exercise (M): 1,667 @ $0 · Option exercise (M): 3,324 @ $0 · Option exercise (M): 1,700 @ $0 · Tax withholding (F): 4,318 @ $170.77 · Option exercise (M): 1,339 (derivative) @ $0 · +3 more | EDGAR |
| 2026-07-02 | 4 | Kalia Kumud — Chief Information Officer | Option exercise (M): 1,607 @ $0 · Option exercise (M): 1,084 @ $0 · Option exercise (M): 1,994 @ $0 · Option exercise (M): 1,361 @ $0 · Tax withholding (F): 3,066 @ $170.77 · Option exercise (M): 1,607 (derivative) @ $0 · +3 more | EDGAR |
| 2026-07-02 | 4 | Freeman Chris — Chief Commercial Officer | Option exercise (M): 1,928 @ $0 · Option exercise (M): 1,667 @ $0 · Option exercise (M): 2,526 @ $0 · Option exercise (M): 1,293 @ $0 · Tax withholding (F): 3,141 @ $170.77 · Option exercise (M): 1,928 (derivative) @ $0 · +3 more | EDGAR |
| 2026-07-02 | 4 | Talasaz AmirAli — Co-Chief Executive Officer, Director | Option exercise (M): 2,817 @ $0 · Tax withholding (F): 1,428 @ $150.03 · Option exercise (M): 23,997 @ $0 · Option exercise (M): 9,715 @ $0 · Tax withholding (F): 17,086 @ $170.77 · Option exercise (M): 2,817 (derivative) @ $0 · +2 more | EDGAR |
| 2026-07-02 | 4 | Eltoukhy Helmy — Co-Chief Executive Officer, Director | Option exercise (M): 2,817 @ $0 · Tax withholding (F): 1,428 @ $150.03 · Option exercise (M): 23,997 @ $0 · Option exercise (M): 9,715 @ $0 · Tax withholding (F): 17,086 @ $170.77 · Option exercise (M): 2,817 (derivative) @ $0 · +2 more | EDGAR |
| 2026-07-02 | 4 | Saia John G. — Chief Legal Officer | Option exercise (M): 974 @ $0 · Option exercise (M): 1,667 @ $0 · Option exercise (M): 2,925 @ $0 · Option exercise (M): 1,497 @ $0 · Tax withholding (F): 3,707 @ $170.77 · Option exercise (M): 974 (derivative) @ $0 · +3 more | EDGAR |
| 2026-07-02 | 4 | Bell Michael Brian — Chief Financial Officer | Option exercise (M): 2,084 @ $0 · Option exercise (M): 3,324 @ $0 · Option exercise (M): 1,870 @ $0 · Tax withholding (F): 3,914 @ $170.77 · Option exercise (M): 2,084 (derivative) @ $0 · Option exercise (M): 3,324 (derivative) @ $0 · +1 more | EDGAR |
| 2026-07-02 | 4 | Krognes Steve E. — Director | Option exercise (M): 155 @ $0 · Option exercise (M): 155 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Monroe Terilyn J. — Chief People Officer | Option exercise (M): 2,659 @ $0 · Option exercise (M): 1,361 @ $0 · Tax withholding (F): 2,099 @ $170.77 · Option exercise (M): 2,659 (derivative) @ $0 · Option exercise (M): 1,361 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Kalia Kumud — Chief Information Officer | Sale (S): 600 @ $130.86 · Purchase (P): 600 @ $130.76 · Sale (S): 600 @ $131.08 | EDGAR |
| 2026-06-30 | 4 | Talasaz AmirAli — Co-Chief Executive Officer, Director | Option exercise (M): 111,804 @ $4.18 · Sale (S): 64,037 @ $150.49 · Sale (S): 52,935 @ $151.16 · Option exercise (M): 143,028 @ $4.18 · Sale (S): 25,812 @ $150.53 · Sale (S): 70,513 @ $151.47 · +4 more | EDGAR |
| 2026-06-23 | 4 | Tariq Musa — Director | Sale (S): 1,951 @ $131.16 | EDGAR |
| 2026-06-23 | 4 | MIGNONE ROBERTO — Director | Option exercise (M): 264 @ $0 · Option exercise (M): 264 @ $0 · Option exercise (M): 264 (derivative) @ $0 · Option exercise (M): 264 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | POTTER MYRTLE S — Director | Sale (S): 1,556 @ $131.16 | EDGAR |
| 2026-06-22 | 4 | Tariq Musa — Director | Option exercise (M): 4,203 @ $0 · Option exercise (M): 4,203 (derivative) @ $0 · Grant/award (A): 2,711 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Hidalgo Medina Manuel — Director | Option exercise (M): 232 @ $0 · Option exercise (M): 4,203 @ $0 · Option exercise (M): 232 (derivative) @ $0 · Option exercise (M): 4,203 (derivative) @ $0 · Grant/award (A): 2,711 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Joyce Meghan V. — Director | Option exercise (M): 4,203 @ $0 · Option exercise (M): 4,203 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Krognes Steve E. — Director | Option exercise (M): 4,203 @ $0 · Option exercise (M): 4,203 (derivative) @ $0 · Grant/award (A): 2,711 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Gadde Vijaya — Director | Option exercise (M): 4,203 @ $0 · Option exercise (M): 4,203 (derivative) @ $0 · Grant/award (A): 2,711 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Azar Alex M II — Director | Grant/award (A): 2,711 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | CLARK IAN T — Director | Option exercise (M): 5,092 @ $0 · Option exercise (M): 5,092 (derivative) @ $0 · Grant/award (A): 2,711 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | MIGNONE ROBERTO — Director | Option exercise (M): 4,203 @ $0 · Option exercise (M): 4,203 (derivative) @ $0 · Grant/award (A): 2,711 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | POTTER MYRTLE S — Director | Option exercise (M): 4,203 @ $0 · Option exercise (M): 4,203 (derivative) @ $0 · Grant/award (A): 2,711 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Kalia Kumud — Chief Information Officer | Option exercise (M): 638 @ $0 · Tax withholding (F): 314 @ $129.82 · Option exercise (M): 638 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Tariq Musa — Director | Option exercise (M): 250 @ $0 · Sale (S): 116 @ $130.19 · Option exercise (M): 250 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Freeman Chris — Chief Commercial Officer | Option exercise (M): 1,402 @ $0 · Tax withholding (F): 594 @ $129.82 · Option exercise (M): 1,402 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Saia John G. — Chief Legal Officer | Option exercise (M): 1,020 @ $0 · Tax withholding (F): 535 @ $129.82 · Option exercise (M): 1,020 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Bell Michael Brian — Chief Financial Officer | Option exercise (M): 2,039 @ $0 · Tax withholding (F): 1,096 @ $129.82 · Option exercise (M): 2,039 (derivative) @ $0 | EDGAR |
Recent 8-K events — Guardant Health, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-24 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2025-09-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →